Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.730
-0.280 (-5.59%)
At close: Jan 20, 2026, 4:00 PM EST
4.740
+0.010 (0.21%)
Pre-market: Jan 21, 2026, 5:23 AM EST
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $206.98 million as of January 21, 2026. Its market cap has decreased by -41.01% in one year.
Market Cap
206.98M
Enterprise Value
205.43M
1-Year Change
-41.01%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $206.98M, a decrease of -59.11%. That is a compound annual growth rate of -16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 206.98M | 0.30% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |